Deferasirox
In Stock•Starting at $8 for 250 mg•Purity ≥ 98%
| CAS No. | 201530-41-8 |
|---|---|
| MDL No. | MFCD09751362 |
| MF | C21H15N3O4 |
| MW | 373.40 |
| InChI Key | BOFQWVMAQOTZIW-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 250 mg | 98% | $8 | In Stock | |
| 1 g | 98% | $14 | In Stock | |
| 5 g | 98% | $36 | In Stock | |
| 25 g | 98% | $100 | In Stock | |
| 100 g | 98% | $283 | In Stock |
Product Information
Deferasirox is a triazole containing a 4-carboxyphenyl group at position 1 and 2-hydroxyphenyl groups at positions 3 and 5. It is an orally active iron chelator used to manage chronic iron overload in patients receiving long-term blood transfusions. It functions as an iron chelator, belongs to the class of triazoles, monocarboxylic acids, benzoic acids, and phenols, and is structurally related to 2,2'-(1-phenyl-1H-1,2,4-triazole-3,5-diyl)diphenol.
| CAS No. | 201530-41-8 |
|---|---|
| Product Name | Deferasirox |
Associated Conditions
African iron overload·Diamond-Blackfan anemia·hereditary hemochromatosis·Thalassemia·sickle cell disease·
* The information provided here is compiled from public sources and is for reference only.